Evidence map›Paper›PMID 40343561›Full record

ReviewDiscover oncology2025

Cathepsin B in urological tumors: unraveling its role and therapeutic potential.

Zhaojie Yan, Guansong Zheng, Junrong Zou, Xiaofeng Zou, Keqiang Chai, Guoxi Zhang

Abstract readReview
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhaojie YanFirst Clinical College, Gannan Medical University, Ganzhou, 341000, China.
Guansong ZhengFirst Clinical College, Gannan Medical University, Ganzhou, 341000, China.
Junrong ZouDepartment of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Xiaofeng ZouDepartment of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
Keqiang ChaiDepartment of Urology, Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, 730900, China. 312306379@qq.com.
Guoxi ZhangDepartment of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. zgx8778@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cathepsin B(CTSB) is a key protease within the lysosomal protease family and is recognized as a tumor-promoting factor that exerts a substantial impact on cancer progression. It plays a critical role in the initiation, proliferation, metastasis, and angiogenesis of cancer, significantly advancing the disease. This review offers a concise overview of the structure and biological functions of CTSB, clarifying its relationship with cancer and the role it plays in the disease's progression. Additionally, we discuss the association between CTSB and several common malignant tumors of the urinary system, highlighting its potential role and clinical significance within these tumors, as well as the challenges that remain.

Indexed as

Bladder cancerCathepsin BProstate cancerRenal cell carcinomaTumor drug resistance

Identifiers

PMID40343561
PMCPMC12064525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.